ES410934A1 - Procedimiento para la preparacion de acidos indolcarboxili-cos. - Google Patents

Procedimiento para la preparacion de acidos indolcarboxili-cos.

Info

Publication number
ES410934A1
ES410934A1 ES410934A ES410934A ES410934A1 ES 410934 A1 ES410934 A1 ES 410934A1 ES 410934 A ES410934 A ES 410934A ES 410934 A ES410934 A ES 410934A ES 410934 A1 ES410934 A1 ES 410934A1
Authority
ES
Spain
Prior art keywords
preparation
acids
indolcarboxili
cos
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES410934A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES410934A1 publication Critical patent/ES410934A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES410934A 1972-01-26 1973-01-24 Procedimiento para la preparacion de acidos indolcarboxili-cos. Expired ES410934A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722203542 DE2203542A1 (de) 1972-01-26 1972-01-26 Blutzuckersenkende indolcarbonsaeurederivate und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ES410934A1 true ES410934A1 (es) 1975-12-01

Family

ID=5834053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES410934A Expired ES410934A1 (es) 1972-01-26 1973-01-24 Procedimiento para la preparacion de acidos indolcarboxili-cos.

Country Status (25)

Country Link
JP (1) JPS5930703B2 (cg-RX-API-DMAC10.html)
AR (2) AR194640A1 (cg-RX-API-DMAC10.html)
AT (3) AT327885B (cg-RX-API-DMAC10.html)
AU (1) AU465326B2 (cg-RX-API-DMAC10.html)
BE (1) BE794483A (cg-RX-API-DMAC10.html)
CA (1) CA983511A (cg-RX-API-DMAC10.html)
CH (2) CH586677A5 (cg-RX-API-DMAC10.html)
CS (2) CS164221B2 (cg-RX-API-DMAC10.html)
DD (1) DD103642A5 (cg-RX-API-DMAC10.html)
DE (1) DE2203542A1 (cg-RX-API-DMAC10.html)
DK (1) DK134517C (cg-RX-API-DMAC10.html)
EG (1) EG10793A (cg-RX-API-DMAC10.html)
ES (1) ES410934A1 (cg-RX-API-DMAC10.html)
FI (1) FI55829C (cg-RX-API-DMAC10.html)
FR (1) FR2169181B1 (cg-RX-API-DMAC10.html)
GB (2) GB1369577A (cg-RX-API-DMAC10.html)
HU (1) HU164871B (cg-RX-API-DMAC10.html)
IL (1) IL41350A (cg-RX-API-DMAC10.html)
NL (1) NL154420B (cg-RX-API-DMAC10.html)
NO (1) NO140007C (cg-RX-API-DMAC10.html)
PL (2) PL89093B1 (cg-RX-API-DMAC10.html)
SE (1) SE388196B (cg-RX-API-DMAC10.html)
SU (2) SU509219A3 (cg-RX-API-DMAC10.html)
YU (2) YU17473A (cg-RX-API-DMAC10.html)
ZA (1) ZA73545B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5579169A (en) * 1978-12-12 1980-06-14 Seiko Epson Corp Ink jet type recorder
US4510157A (en) * 1982-12-27 1985-04-09 Ayerst, Mckenna & Harrison, Inc. 6,7,8,9-Tetrahydro-1H-benz(g)indol-8-amine derivatives
US4470990A (en) * 1983-03-14 1984-09-11 Ayerst, Mckenna & Harrison Inc. 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
FR2768146B1 (fr) * 1997-09-05 2000-05-05 Oreal Nouveaux composes de la famille des indole-carboxyliques et leur utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332846A (en) * 1965-03-02 1967-07-25 American Cyanamid Co Method of inducing hypoglycemia with a substituted indole

Also Published As

Publication number Publication date
JPS4881855A (cg-RX-API-DMAC10.html) 1973-11-01
NO140007C (no) 1979-06-20
GB1369577A (en) 1974-10-09
YU17473A (en) 1981-11-13
NL154420B (nl) 1977-09-15
DE2203542C2 (cg-RX-API-DMAC10.html) 1988-01-21
JPS5930703B2 (ja) 1984-07-28
IL41350A0 (en) 1973-03-30
SE388196B (sv) 1976-09-27
NL7300871A (cg-RX-API-DMAC10.html) 1973-07-30
IL41350A (en) 1975-02-10
FI55829C (fi) 1979-10-10
EG10793A (en) 1976-05-31
FR2169181A1 (cg-RX-API-DMAC10.html) 1973-09-07
AR195134A1 (es) 1973-09-10
AU5137473A (en) 1974-07-25
DK134517B (da) 1976-11-22
CA983511A (en) 1976-02-10
AT320634B (de) 1975-02-25
PL89093B1 (cg-RX-API-DMAC10.html) 1976-10-30
ZA73545B (en) 1973-11-28
CS164222B2 (cg-RX-API-DMAC10.html) 1975-11-07
HU164871B (cg-RX-API-DMAC10.html) 1974-05-28
YU179579A (en) 1981-11-13
DD103642A5 (cg-RX-API-DMAC10.html) 1974-02-05
DK134517C (da) 1977-04-25
AT327885B (de) 1976-02-25
FI55829B (fi) 1979-06-29
NO140007B (no) 1979-03-12
DE2203542A1 (de) 1973-08-16
AR194640A1 (es) 1973-07-31
CH586677A5 (cg-RX-API-DMAC10.html) 1977-04-15
SU509219A3 (ru) 1976-03-30
CS164221B2 (cg-RX-API-DMAC10.html) 1975-11-07
ATA62074A (de) 1975-05-15
SU530642A3 (ru) 1976-09-30
FR2169181B1 (cg-RX-API-DMAC10.html) 1976-04-09
CH587816A5 (cg-RX-API-DMAC10.html) 1977-05-13
GB1369578A (en) 1974-10-09
BE794483A (fr) 1973-07-24
PL92384B1 (cg-RX-API-DMAC10.html) 1977-04-30
AU465326B2 (en) 1975-09-25

Similar Documents

Publication Publication Date Title
BG30015A3 (bg) Метод за получаване на трифенилалкенови производни
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
BG31949A3 (en) Method for obtaining derivatives of phenyl- 2- indol
SE7410090L (sv) Herbicid komposition.
ES389180A1 (es) Procedimiento para la preparacion de derivados de la dihi- dro-3,4 isoquinoleina.
BG28699A3 (bg) Метод за получаване на алкилендиаминови производни
SU437293A3 (ru) Способ получения рацемических или оптически активных производных пиперазина
ES418527A1 (es) Procedimiento para la obtencion de colorantes reactivos concelulosa.
BG32853A3 (bg) Метод за получаване на 1- оксадетиацефалоспорини
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG35746A3 (bg) Метод за получаване на 1-циклохексенилметил прдукти
ES410934A1 (es) Procedimiento para la preparacion de acidos indolcarboxili-cos.
BG32849A3 (en) Method for obtaining of 2- chlor- 4- substituated derivatives of thiazolcarbonic acids
BG31504A3 (bg) Метод за получаване на депостероидни естери
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
BG33292A3 (bg) Метод за получаване на пенамсулфоокисни производни
BG31503A3 (en) Method for obtaining the derivatives of octahjdroindolhinolzine
BG35749A3 (bg) Метод за получаване на 20-дихидро-20,23-дидеокситидонолид
ES481872A1 (es) Un procedimiento para la preparacion de derivados del 3-azo-biciclo (3.1.0) hexano.
ES457370A1 (es) Procedimiento de preparacion de nuevos derivados del nafta- leno.
BG34037A3 (bg) Метод за получаване на субституирани n-метиленови производни на тиенамицина
BG31948A3 (en) Method for obtaining of derivatives of phenyl- 2- indol
SE7508857L (sv) Forfarande for framstellning av 19,20-bis-norprostansyror.
ES478110A1 (es) Un procedimiento para preparar derivados de 3-azabiciclo(3.-1.0)hexano.
ES423950A1 (es) Procedimiento para la preparacion de 3 - carbetoxihidrazino- piridazinas - 6 - sustituidas.